We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

316 hedge funds and large institutions have $2.86B invested in GW Pharmaceuticals Plc American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 103 increasing their positions, 82 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $256M | Put options by funds: $159M

26% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 82

1% less funds holding

Funds holding: 318 → 316 (-2)

2% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 51

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

34% less capital invested

Capital invested by funds: $4.35B → $2.86B (-$1.49B)

Holders
316
Holders Change
-2
Holders Change %
-0.63%
% of All Funds
6.93%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
50
Increased
103
Reduced
82
Closed
51
Calls
$256M
Puts
$159M
Net Calls
+$97.1M
Net Calls Change
+$143M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$130M
2
Citadel Advisors
Citadel Advisors
Florida
+$84.2M
3
Morgan Stanley
Morgan Stanley
New York
+$48.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$45.5M
5
Holocene Advisors
Holocene Advisors
New York
+$39.1M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$268M
2
RSCM
Rock Springs Capital Management
Maryland
-$77.4M
3
MWNA
Marshall Wace North America
New York
-$57.5M
4
OAM
Oberweis Asset Management
Illinois
-$36.7M
5
Macquarie Group
Macquarie Group
Australia
-$33.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
JCM
301
Jacobi Capital Management
Pennsylvania
$2K – – –
RFA
302
Reilly Financial Advisors
California
$2K – – –
RFM
303
Royal Fund Management
Florida
$2K – – –
TIM
304
Tortoise Investment Management
New York
$2K – – –
WAS
305
Winch Advisory Services
Wisconsin
$2K – – –
AF
306
Advisornet Financial
Minnesota
$2K +$455 +3 +19%
ME
307
McIlrath & Eck
Washington
$2K +$2.28K +15 New
CCM
308
Covington Capital Management
California
$2K +$3.04K +20 New
CHC
309
City Holding Co
West Virginia
$1K – – –
AA
310
Advisory Alpha
Michigan
$776 +$1.06K +7 New
GT
311
Glenmede Trust
Pennsylvania
$34 – – –
PC
312
Polar Capital
United Kingdom
– -$26.8M -155,658 Closed
CM
313
Castleark Management
Illinois
– -$9.43M -54,690 Closed
ACM
314
Atika Capital Management
New York
– -$9.31M -54,000 Closed
MA
315
MYDA Advisors
New York
– -$4.25M -28,000 Closed
SGH
316
Sivik Global Healthcare
Connecticut
– -$4.31M -25,000 Closed
CIP
317
Chartwell Investment Partners
Pennsylvania
– -$3.84M -22,287 Closed
IWA
318
IBEX Wealth Advisors
New Jersey
– -$2.05M -11,896 Closed
AWM
319
AE Wealth Management
Kansas
– -$771K -4,473 Closed
GGHC
320
Gilder Gagnon Howe & Co
New York
– -$494K -2,864 Closed
Mackenzie Financial
321
Mackenzie Financial
Ontario, Canada
– -$378K -2,194 Closed
Twin Tree Management
322
Twin Tree Management
Texas
– -$372K -2,158 Closed
DCM
323
Driehaus Capital Management
Illinois
– -$369K -2,142 Closed
BAM
324
Blueshift Asset Management
New Jersey
– -$342K -1,983 Closed
Mariner
325
Mariner
Kansas
– -$321K -1,863 Closed
11 12
13
14 15

GWPH Hedge Fund Activity: Q3 2019 in Review

316 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2019, worth a combined $2.86B — down 34% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of GWPH and 50 opened new positions — a net loss of 1 holder — while 82 trimmed existing stakes and 103 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $130M. The largest seller was Capital World Investors, cutting an estimated $268M.

  • 316 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $2.86B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2019, down 34% quarter-over-quarter.
  • 50 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2019 and 51 closed out, a net change of -1 holder.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2019 was Millennium Management, an estimated $130M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2019 was Capital World Investors, an estimated $268M sold.

Based on aggregated 13F filings for Q3 2019.